An FDA advisory committee voted to recommend emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The panel voted to recommend approval with 17 votes for approval, four against and one abstaining.
Some committee members voiced concerns that 16 and 17-year-olds could get the vaccine, despite few people in that age group taking part in the vaccine trials.
All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub and follow our live updates page for the most recent information on the COVID-19 pandemic.
An independent advisory committee for the Food and Drug Administration voted Thursday to